Doxazosin for the management of distal-ureteral stones

Journal of Endourology

Volumn 21, Issue 5, 2007, Pages 538-541

  Liatsikos, E N ^a,d   Katsakiori, P F ^a   Assimakopoulos, K ^a   Voudoukis, T ^a   Kallidonis, P ^a   Constantinides, C ^b   Athanasopoulos, A ^a   Stolzenburg, Jens Uwe ^c   Perimenis, P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URETER STONE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; COLIC; DOXAZOSIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; SAMPLE SIZE; TREATMENT OUTCOME; URETERAL CALCULI;

EID: 34249905444     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.0107     Document Type: Article

References (31)

1. Sierakowski R, Finlayson B, Landes RR, Finlayson CD, Sierakowski N. The frequency of urolithiasis in hospital discharge diagnoses in the United Stales. Invest Urol 1978;15:438-441.
2. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in a prepaid medical care system. Am J Epidemiol 1982;115:255-265.
3. Morse RM, Resnick MI. Ureteral calculi: Natural history and treatment in an era of advanced technology. J Urol 1991;145:263-265.
4. Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology 2000;56:575-578.
5. Whitfield HN. The management of ureteric stones II: Therapy. BJU Int 1999;84:916-921.
6. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN. Ureteral stones Clinical Guidelines Panel summary report on the management of ureteral calculi. J Urol 1997;158:1915-1921.
7. Kupeli B, Biri H, Isen K, Onaran M, Alkibay T, Karaolan U, Bozkirli I. Treatment of ureteral stones: Comparison of extracorporeal shock wave lithotripsy and endourologic alternatives. Eur Urol 1998;34:474-479.
8. Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Management of ureteral calculi: A cost comparison and decision analysis. J Urol 2002;167:1621-1629.
9. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: A guide for patient education. J Urol 1999;162:688-691.
10. Ueno A, Kawamura T, Ogawa A, Takayasu H. Relation of spontaneous passage of ureteral calculi to size. Urology 1977;10: 544-546.
11. Fox M, Pyrah LN, Raper FP. Management of ureteric stone: A review of 292 cases. Br J Urol 1965;37:660-670.
12. Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993;24: 172-176.
13. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 2002;178:101-103.
14. Hussain Z, Inman RD, Elves AWS, Shipstone DP, Ghiblawi S, Coppinger SWV. Use of glyceryl trinitrate patches in patients with ureteral stones: A randomized, double-blind, placebo-controlled study. Urology 2001;58:521-525.
15. Andersson KE, Forman A. Effects of calcium channel blockers on urinary tract smooth muscle. Acta Pharmacol Toxicol (Copenh) 1986;58(suppl 2):193-200.
16. Smet PJ, Edyvane KA, Jonavicius J, Marshall VR. Colocalization of nitric oxide synthetase with vasoactive intestinal peptide, neuropeptide Y, and tyrosine hydroxylase in nerves supplying the human ureter. J Urol 1994;152:1292-1296.
17. Stief CG, Uckert S, Truss MC, Becker AJ, Machtens S, Jonas U. A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 1996;24:333-337.
18. Bajor G. Beta-blocking agent facilitating the spontaneous passage of ureteral stones. Int Urol Nephrol 1990;22:33-36.
19. Iselin C, Ny L, Larsson B, Schaad NC, Alm P, Graber P, Morel DR, Andersson KE. The nitric oxide synthase/nitric oxide and heme oxygenase/carbon monoxide pathways in the human ureter. Eur Urol 1998;33:214-221.
20. Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter. Invest Urol 1978;16:123-127.
21. Morita T, Ando M, Kihara K, Oshima H. Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 1994;13:315-321.
22. Peters HJ, Eckstein W. Possible pharmacological means of treating renal colic. Urol Res 1975;3:55-59.
23. Zhong H, Minneman KP. α1-Adrenoceptor subtypes. Eur J Pharmacol 1999;375:261-276.
24. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000;56:579-582.
25. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003;170:2202-2205.
26. Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004;172:568-572.
27. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different α1-adrenergic blockers for distal ureteral stones. J Urol 2005;173:2010-2012.
28. Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, Bozkirli I. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004;64:1111-1115.
29. Ramage AG, Wyllie MG. A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats. Eur J Pharmacol 1995;294:645-650.
30. Malin JM Jr, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol 1970;42:171-174.
31. Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol 2003;169:1520-1525.